Journal of Affective Disorders
Volume 85, Issue 1 , Pages 217-230 , March 2005

Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers

  • Alvaro Camacho

      Affiliations

    • Corresponding Author InformationCorresponding author. International Mood Center, Department of Psychiatry, University of California, San Diego (UCSD), 9500 Gilman Drive, La Jolla, CA 92093-0603R, USA.
    • ,
  • Hagop S. Akiskal

Received 8 January 2003 ,Accepted 23 October 2003.

References 

  1. Akiskal HS. The distinctive mixed states of bipolar I, II and III. Clin. Neuropharmacol. 1992;15(Suppl. 1A):632–633
  2. Akiskal HS, Mallya G. Criteria for the “soft” bipolar spectrum: treatment implications. Psychopharmacol. Bull. 1987;23:68–73
  3. Akiskal HS, Pinto O. The evolving bipolar spectrum: prototypes I, II, III, IV. Psychiatr. Clin. North Am. 1999;22:517–534
  4. Akiskal HS, Djenderedjian AH, Rosenthal RH, Khani MK. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am. J. Psychiatry. 1977;134:1227–1233
  5. Akiskal HS, Khani MK, Scott-Strauss A. Cyclothymic temperamental disorders. Psychiatr. Clin. North Am. 1979;2:527–554
  6. Akiskal HS, Downs J, Jordan P, Watson S, Daugherty D, Pruitt DB. Affective disorders in the referred children and younger siblings of manic-depressives: mode of onset and prospective course. Arch. Gen. Psychiatry. 1985;42:996–1003
  7. Akiskal HS, Maser JD, Zeller P, Endicott J, Coryell W, Keller M, et al. Switching from “unipolar” to bipolar II: an 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch. Gen. Psychiatry. 1995;52:114–123
  8. Akiskal HS, Placidi GF, Signoretta S, Liguori A, Gervasi R, Maremmani I, et al. TEMPS-I: delineating the most discriminant traits of cyclothymic, depressive, irritable and hyperthymic temperaments in a nonpatient population. J. Affect. Disord. 1998;51:7–19
  9. Akiskal HS, Hantouche EG, Allilaire J-F. Bipolar II with and without cyclothymic temperament: “dark” and “sunny” expressions of soft bipolarity. J. Affect. Disord. 2003;73:49–57
  10. Akiskal HS, Hantouche EG, Allilaire JF, Sechter D, Bourgeois ML, Azorin JM, et al. Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J. Affect. Disord. 2003;73:65–74
  11. Akiskal HS, Mendlowicz MV, Jean-Louis G, Rapaport MH, Kelsoe JR, Gillin JC, et al. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J. Affect. Disord. 2005;85:45–52
  12. Akiskal HS, Akiskal KK, Haykal RF, Manning JS, Connor PD. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J. Affect. Disord. 2005;85:3–16
  13. Brady KT, Sonne SC. The relationship between substance abuse and bipolar disorder. J. Clin. Psychol. 1995;56(Suppl. 3):19–24
  14. Brady KT, Sonne SC, Anton R, Ballenger JC. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J. Clin. Psychol. 1995;56:118–121
  15. Brady KT, Sonne SC, Malcolm RJ, Randall CL, Dansky BS, Simpson K, et al. Carbamazepine in cocaine dependent individuals with affective disorder. Exp. Clin. Psychopharmacol. 2002;10:276–285
  16. Brown SE, Nejtek VA, Perantie DA, Bobadilla L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord. 2002;4:406–411
  17. Brown SE, Nejtek VA, Perantie DC, Orsulak PJ, Bobadilla L. Lamotrigine in patients with bipolar disorder and cocaine dependence. J. Clin. Psychol. 2003;64:197–201
  18. Calabrese JR, Shelton MD, Bowden CL, Rapport DJ, Suppes T, Shirley ER, et al. Bipolar rapid cycling: focus on depression as its hallmark. J. Clin. Psychiatry. 2001;62(Suppl. 14):34–41
  19. Cassidy F. Substance abuse in bipolar disorder. Bipolar Disord. 2001;3:181–188
  20. Chengappa KN, Levine J, Gershon S, Kupfer DJ. Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. Bipolar Disord. 2000;2(3Pt. 1):191–195
  21. Compton WM, Cottler LB, Phelps DL, Ben Abdallah A, Spitznagel EL. Psychiatric disorders among drug dependent subjects: are they primary or secondary. Am. J. Addict. 2000;9:126–134
  22. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, et al. Desipramine facilitation of initial cocaine abstinence. Arch. Gen. Psychiatry. 1989;46:117–121
  23. Khantzian EJ. Self medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry. 1985;142:1259–1264
  24. Khantizian EJ. The self medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry. 1997;4:231–244
  25. Lemere F, Smith JW. Hypomanic personality trait in cocaine addiction. Br. J. Addict. 1990;85:575–576
  26. Majewska MD. Cocaine addiction as a neurological disorder: implications for treatment. NIDA Res. Monogr. 1996;163:1–26
  27. Maremmani I, Capone MR, Aglietti M, Castrogiovanni P. Heroin dependence and bipolar disorders. New Trends Exp. Clin. Psychiatry. 1994;X:179–182
  28. Maremmani I, Pacini M, Lubrano S, Lovrecic M, Perugi G. Dual diagnosis heroin addicts. The clinical and therapeutic aspects. Heroin Addict. Rel. Clin. Probl. 2003;5:7–98
  29. Margolin A, Avants SK, DePhilippis D, Kosten TR. A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. Am. J. Drug Alcohol Abuse. 1998;24:85–101
  30. Oliveto A, McCance-Kantz FE, Singha A, Petrakis I, Hameedi F, Kosten TR. Effects of cocaine prior to and during bupropion treatment maintenance in cocaine-abusing volunteers. Drug Alcohol Depend. 2001;63:155–167
  31. Perugi G, Frare F, Madaro D, Maremmani I, Akiskal HS. Alcohol abuse in social phobic patients: is there a bipolar connection?. J. Affect. Disord. 2002;68:33–39
  32. Pinto O, Akiskal HS. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder. J. Affect. Disord. 1998;51:333–343
  33. Placidi GF, Signoretta S, Liguori A, Gervasi R, Maremmani I, Akiskal HS. The semi-structured affective temperament Interview (TEMPS-I): reliability and psychometric properties in 1010 14–26 year students. J. Affect. Disord. 1998;47:1–10
  34. Ranaldi R, Poeggel K. Baclofen decreases methamphetamine self-administration in rats. Neuroreport. 2002;13:1107–1110
  35. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Cathchment Area (ECA) Study. JAMA. 1990;264:2511–2518
  36. Rosenblum A, Fallon B, Magura S, Handelsman L, Foote J, Bernstein D. The autonomy of mood disorders among cocaine-using methadone patients. Am. J. Drug Alcohol Abuse. 1999;25:67–80
  37. Rosethal RN, Westriech L. Treatment of persons with dual diagnosis of substance use disorder and other psychological problems. In:  McCrady BS,  Epstein EE editor. Addictions: A Comprehensive Textbook. New York: Oxford Press; 1999;p. 439–476
  38. Sachs GS. Decision tree for the treatment of bipolar disorder. J. Clin. Psychiatry. 2003;64:35–40
  39. Salloum IM, Thase ME. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord. 2000;2:268–280
  40. Silverstone PH, Pukhovsky A, Rotzinger S. Lithium does not attenuate the effects of d-amphetamine in healthy volunteers. Psychiatry Res. 1998;79:219–226
  41. Sutor B, Tinsley JA, Morse RM. Management of patients with bipolar mood disorder and substance dependence. J. Addict. Disord. 1999;18:83–93
  42. Tohen M, Greenfield SF, Weiss RD, Zarate CA, Vagge LM. The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harv. Rev. Psychiatry. 1998;6:133–141
  43. Van Kammen DP, Murphy DL. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia. 1975;44:215–224
  44. Weiss RD. Relapse to cocaine abuse after initiating desipramine treatment. JAMA. 1988;260:2545–2546
  45. Weiss RD, Mirin SM, Griffin ML, Michael JL. Psychopathology in cocaine abusers. Changing trends. J. Nerv. Ment. Dis. 1998;176:719–725
  46. Winokur G, Turvey C, Akiskal H, Coryell W, Solomon D, Leon A, et al. Alcoholism and drug abuse in three groups—bipolar I, unipolars and their acquaintances. J. Affect. Disord. 1998;50:81–89
  47. Wu LT, Kouzis AC, Leaf PJ. Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. Am. J. Psychiatry. 1999;156:1230–1236

PII: S0165-0327(03)00323-9

doi: 10.1016/j.jad.2003.10.014

Journal of Affective Disorders
Volume 85, Issue 1 , Pages 217-230 , March 2005

Article Tools